VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke Patients
Sea Mi Park, Jong-Keuk Lee, Sa Il Chun, Hae In Lee, Sun U. Kwon, Dong-Wha Kang, Jong S. Kim
J Stroke. 2013;15(2):115-121.   Published online 2013 May 31     DOI: https://doi.org/10.5853/jos.2013.15.2.115
Citations to this article as recorded by Crossref logo
Clinical verification of Lou type warfarin pharmacokinetic dosing algorithms equation
Jiangang Jiang, Ningning Ji, Jingliang Lan, Xiaoping Ge, Xiaoma Du
Molecular Medicine Reports.2018;[Epub]     CrossRef
Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines Part 2
Sollip Kim, Yeo-Min Yun, In-Suk Kim, Sang Hoon Song, Hye In Woo, Kyung-A Lee, Woochang Lee, Hyun-Jung Cho, Misuk Ji, Hyo-Jin Chae, Soo-Youn Lee, Sail Chun
Laboratory Medicine Online.2016; 6(4): 193.     CrossRef
Clinical Application of Genotype-guided Dosing of Warfarin in Patients with Acute Stroke
Svjetlana Šupe, Zdravka Poljaković, Tamara Božina, Josip Ljevak, Viola Macolić Šarinić, Nada Božina
Archives of Medical Research.2015; 46(4): 265.     CrossRef
Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
Huey Yi Chong, Surasak Saokaew, Kuntika Dumrongprat, Unchalee Permsuwan, David Bin-Chia Wu, Piyamitr Sritara, Nathorn Chaiyakunapruk
Thrombosis Research.2014; 134(6): 1278.     CrossRef
Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 — Implications for warfarin management and outcome in Croatian patients with acute stroke
Svjetlana Šupe, Nada Božina, Vesna Matijević, Antonela Bazina, Antonija Mišmaš, Josip Ljevak, Domagoj Alvir, Mario Habek, Zdravka Poljaković
Journal of the Neurological Sciences.2014; 343(1-2): 30.     CrossRef
New advances in the treatment of atrial fibrillation: focus on stroke prevention
Yee C Lau, Gregory YH Lip
Expert Opinion on Pharmacotherapy.2014; 15(15): 2193.     CrossRef